Clinical utility of (188)Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

(188)Rhenium-hydroxyethylidene-1,1-diphosphonate ((188)Re-HEDP) is a clinically established radiopharmaceutical for bone pain palliation of patients with metastatic bone cancer. Herein, the effectiveness of (188)Re-HEDP for the palliation of painful bone metastases was investigated in an uncontrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinto, Ajit S., Mallia, Madhava B., Kameswaran, Mythili, Kamaleshwaran, K. K., Joseph, Jephy, Radhakrishnan, E. R., Upadhyay, Indira V., Subramaniam, R., Sairam, Madhu, Banerjee, Sharmila, Dash, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216741/
https://www.ncbi.nlm.nih.gov/pubmed/30505219
http://dx.doi.org/10.4103/wjnm.WJNM_68_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216741/
https://www.ncbi.nlm.nih.gov/pubmed/30505219
http://dx.doi.org/10.4103/wjnm.WJNM_68_17

Ejemplares similares